Issued Patents All Time
Showing 1–25 of 30 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12325695 | 5-(4-pyridyloxy)pyrazole compounds serving as TGF-βR1 kinase inhibitor | Xiangyu FU, Charles Z. Ding, Shuhui CHEN | 2025-06-10 |
| 12221432 | Estrogen receptor antagonist | Shuwen DUAN, Jianyu LU, Charles Z. Ding, Guoping HU, Jian Li +1 more | 2025-02-11 |
| 12122780 | Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor | Xile LIU, Charles Z. Ding, Shuhui CHEN, Haiwen Wan | 2024-10-22 |
| 12098127 | Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor | Huijun HE, Shenyi Shi, Jianyu LU, Charles Z. Ding, Bin Shi +3 more | 2024-09-24 |
| 12018014 | Pyrrole-substituted indolone derivative or pharmaceutically acceptable salts thereof, and preparation method therefor and application thereof | — | 2024-06-25 |
| 11718610 | Compounds containing benzosultam | Xile LIU, Charles Z. Ding, Shuhui CHEN, Haiwen Wan, Xiu Jiang | 2023-08-08 |
| 11691974 | 3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors | Xiangyu FU, Charles Z. Ding, Jianyu LU, Wen Jiang, Jian Li +1 more | 2023-07-04 |
| 11655248 | Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor | Yaxian Cai, Zhaobing Xu, Hailong Yang, Shiqi Han, Guoping HU +3 more | 2023-05-23 |
| 11623923 | Uracil compound as c-MET/AXL inhibitor | Jinping LI, Xiongbin XU, Gang Li, Charles Z. Ding, Yaling Zhou +3 more | 2023-04-11 |
| 11530196 | Pyrimidine compound acting on EGFR and ERBB2 | Charles Z. Ding, Lu Zhang, Xile LIU, Wen Jiang, Jian Li +1 more | 2022-12-20 |
| 11465986 | Crystal form of c-MET inhibitor and salt form thereof and preparation method therefor | Xiongbin XU, Gang Li, Ting YAO, Kun Wang, Charles Z. Ding | 2022-10-11 |
| 11453667 | Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor | Yaxian Cai, Zhaobing Xu, Hailong Yang, Shiqi Han, Guoping HU +3 more | 2022-09-27 |
| 11390625 | Aryl-phosphorus-oxygen compound as EGFR kinase inhibitor | Lingyun WU, Xile LIU, Charles Z. Ding, Shuhui CHEN, Lele ZHAO +5 more | 2022-07-19 |
| 11358950 | SMAC mimetics used as IAP inhibitors and use thereof | Yingchun Liu, Zhaobing Xu, Charles Z. Ding, Xingxun Zhu, Guoping HU +2 more | 2022-06-14 |
| 11261196 | Salt serving as AKT inhibitor and crystal thereof | Gang Li, Lun Lu, Qingqing Lu, Charles Z. Ding | 2022-03-01 |
| 11236112 | Crystal form and salt form of TGF-βRI inhibitor and preparation method therefor | Lifang Wu, Huijun HE, Jianyu LU, Charles Z. Ding, Weidong Li +3 more | 2022-02-01 |
| 11040984 | Quinazoline compound for EGFR inhibition | Xile LIU, Charles Z. Ding, Shuhui CHEN, Lingyun WU, Haiwen Wan | 2021-06-22 |
| 11034653 | Crystal form of estrogen receptor inhibitor and preparation method therefor | Huijun HE, Jianyu LU, Weidong Li, Shenyi Shi, Zhijuan Chen +3 more | 2021-06-15 |
| 10774081 | Indolo substituted piperidine compound as estrogen receptor down-regulator | Jianyu LU, Charles Z. Ding, Xu ZENG, Huijun HE, Shuhui CHEN +2 more | 2020-09-15 |
| 10676474 | 1,6-naphthyridine derivatives as CDK4/6 inhibitor | Zhaobing Xu, Charles Z. Ding, Shuhui CHEN | 2020-06-09 |
| 10654868 | Dihydropyrazole azepine compound serving as Akt inhibitor | Lun Lu, Zhibo Zhang, Gang Li, Charles Z. Ding, Shuhui CHEN | 2020-05-19 |
| 10626107 | Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor | Charles Z. Ding, Shuhui CHEN, Zhaobing Xu, Yingchun Liu, Bingjie Ren +4 more | 2020-04-21 |
| 10519143 | Substituted-indole-compounds as estrogen receptor down-regulators | Jianyu LU, Charles Z. Ding, Huijun HE, Shuhui CHEN, Jiaqiang Dong +1 more | 2019-12-31 |
| 10501443 | Pyridone compound as c-met inhibitor | Xiongbin XU, Gang Li, Charles Z. Ding, Guoping HU, Jian Li +3 more | 2019-12-10 |
| 10233193 | Fused tricyclic heterocyclic compounds useful for treating HIV infection | Tao Yu, Thomas H. Graham, Sherman T. Waddell, John A. McCauley, Andrew Stamford +3 more | 2019-03-19 |